GE HealthCare price target raised to $94 from $92 at Mizuho

Mizuho analyst Anthony Petrone raised the firm’s price target on GE HealthCare to $94 from $92 and keeps a Buy rating on the shares. Despite a solid beat in Q1, the shares "took a breather" with bookings, backlog, and the Imaging margin profile emerging as key debates following the call, the analyst tells investors in a research note. The firm sees an attractive entry point at current share levels, citing strong underlying capital demand.